Case Study: IMIDEX improves lung nodule detection and secures FDA clearance with V7 Darwin

IMIDEX boosts lung nodule detection sensitivity to 83% with V7 Labs

IMIDEX, a healthcare company, needed to achieve FDA clearance for its AI that detects lung nodules in chest X-rays. Their challenge was to generate a vast, high-quality training dataset and execute complex clinical studies under strict medical regulations. They turned to V7 Labs and used the V7 Darwin platform to manage their data and annotation workflows.

Using V7's customizable workflows and DICOM tools, IMIDEX annotated chest X-rays and ran multi-site clinical studies. This resulted in the FDA clearance of their product, VisiRad XR. The model achieved 83% sensitivity, a nearly 30% improvement over radiologists in regular practice. V7's solution enabled IMIDEX to build a tool that could identify up to 1.3 million additional lung nodules annually, helping to detect cancer earlier and save lives.

IMIDEX